Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07480018 · ClinicalTrials.gov registry record · NA

Berberine Supplementation, Sprint Interval Training, and Immune Function Study

A NA study of Inflammation Biomarkers and Wellbeing, sponsored by University of Northern Colorado.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07480018 is a NA study of Inflammation Biomarkers and Wellbeing that is actively recruiting participants, run by University of Northern Colorado. The registered enrollment target is 40 participants, below the 55-participant average among 4 other Inflammation Biomarkers trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07480018, a NA study of Inflammation Biomarkers and Wellbeing, is actively recruiting participants, sponsored by University of Northern Colorado.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencing mild mental health challenges. The main questions it aims to answer are: * Does short-term berberine use or sprint training improve measures of mental health, psychological wellbeing, fatigue, and sleep quality? * Does short-term berberine use or sprint training improve measures of anaerobic power generation? * Does short-term berberine use or sprint training improve circulating biomarkers of inflammation? * Does short-term berberine use or sprint training improve monocyte number, function, and cytokine production?

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Berberine
  • OTHER Sprint Interval Training

Study Locations (1)

Colorado

  • University of Northern Colorado - Greeley

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-01-01
Est. Completion 2026-06-01
Phase NA

Sponsor

University of Northern Colorado

7 total trials

What the Registry Record Tells You About NCT07480018

The ClinicalTrials.gov registry entry for NCT07480018 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55-participant average among 4 other Inflammation Biomarkers trials with a reported enrollment target (27% lower). The listed sponsor is University of Northern Colorado, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Inflammation Biomarkers appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT07480018 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT07480018 about?

NCT07480018 is a clinical study titled "Berberine Supplementation, Sprint Interval Training, and Immune Function Study". The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencin...

What is the current status of trial NCT07480018?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01-01. Estimated completion is 2026-06-01.

What conditions does trial NCT07480018 study?

This clinical trial studies the following conditions: Inflammation Biomarkers, Wellbeing, Berberine, Sprint Training, Anaerobic Power.

What interventions are being tested in trial NCT07480018?

The interventions under investigation include: Placebo (OTHER), Berberine (DIETARY_SUPPLEMENT), Sprint Interval Training (OTHER).

Who is sponsoring clinical trial NCT07480018?

This trial is sponsored by University of Northern Colorado, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07480018 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation Biomarkers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.